Literature DB >> 15023274

Reducing Genital Herpes Transmission Using Antiviral Therapy.

Noreen A. Hynes.   

Abstract

Year:  2004        PMID： 15023274     DOI： 10.1007/s11908-996-0008-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  7 in total

1.  How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis?

Authors:  Anna Wald; Lawrence Corey
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

2.  Herpes simplex virus type 2 in the United States, 1976 to 1994.

Authors:  D T Fleming; G M McQuillan; R E Johnson; A J Nahmias; S O Aral; F K Lee; M E St Louis
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

3.  A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.

Authors:  A G Langenberg; L Corey; R L Ashley; W P Leong; S E Straus
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

4.  Virologic characteristics of subclinical and symptomatic genital herpes infections.

Authors:  A Wald; J Zeh; S Selke; R L Ashley; L Corey
Journal:  N Engl J Med       Date:  1995-09-21       Impact factor: 91.245

Review 5.  Progress in meeting today's demands in genital herpes: an overview of current management.

Authors:  Raj Patel
Journal:  J Infect Dis       Date:  2002-10-15       Impact factor: 5.226

Review 6.  Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.

Authors:  Stephen K Tyring; David Baker; Wendy Snowden
Journal:  J Infect Dis       Date:  2002-10-15       Impact factor: 5.226

7.  Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.

Authors:  T Schacker; A J Ryncarz; J Goddard; K Diem; M Shaughnessy; L Corey
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.